September 21, 2015

Rituximab in refractory sarcoidosis: a single centre experience

Case Report

Open Access

Francesco CinettoNicolò CompagnoRiccardo ScarpaGiacomo Malipiero and Carlo Agostini*
Sarcoidosis is a granulomatous disease whose outcome varies from spontaneous remission to chronic refractory disease. Provided that steroids represent the gold standard as a first line treatment, many immune suppressants drugs are currently used in the disease management. However, refractory disease is still a great challenge. Rituximab is an anti-CD20 chimeric monoclonal antibody, currently used for the treatment of B cell malignancies and systemic autoimmune diseases.

High Prevalence of Neutrophil Cytoplasmic Autoantibodies in Infants with Food Protein-Induced Proctitis/Proctocolitis: Autoimmunity Involvement?

Journal of Immunology Research
Volume 2015 (2015), Article ID 902863, 8 pages
http://dx.doi.org/10.1155/2015/902863
Research Article
1Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic
2Immunoflow, 199 00 Prague, Czech Republic
3Laboratory for Artherosclerosis Research, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic
4Laboratory of Cellular and Molecular Immunology, Institute of Microbiology, ASCR, 142 00 Prague, Czech Republic
Abstract
Background. Food protein-induced proctitis/proctocolitis (FPIP) is the most common noninfectious colitis in children in the first year of life. Along with the overall clinical symptoms, diarrhoea and rectal bleeding are the main manifestations of the disease.

FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy

Journal of Immunology Research
Volume 2015 (2015), Article ID 731381, 7 pages
http://dx.doi.org/10.1155/2015/731381
Research Article

Anna Stelmaszczyk-Emmel,1 Anna Zawadzka-Krajewska,2 Eliza Głodkowska-Mrówka,1 and Urszula Demkow1

1Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw, Poland
2Department of Pediatric Pneumonology and Allergology, Medical University of Warsaw, Poland
Abstract
Over the last decades allergic diseases has become a major health problem worldwide. The only specific treatment to date is allergen specific immunotherapy (ASIT). Although it was shown that ASIT generates allergen-tolerant T cells, detailed mechanism underlying its activity is still unclear and there is no reliable method to monitor its effectiveness. The aim of our study was to evaluate ASIT influence on the frequency of forkhead box P3 (FoxP3) Tregs in allergic children with various clinical manifestations.

September 18, 2015

Review on immunotherapy in airway allergen sensitised patients.

 2015 Jul;73(6):263-9.

van der Valk JP1, de Jong NW, Gerth van Wijk R.

Abstract

Allergen immunotherapy is a more than 100-year-old treatment in particular for birch pollen, grass pollen, house dust mite and cat dander sensitised allergic patients. The mechanism of allergen-specific immunotherapy is complex. Different hypotheses have been postulated to explain the mode of action, such as a decrease of the number of tissue mast cells, eosinophils and basophils, an increase of IgG4 and IgA synthesis, a shift from Th2 to Th1 cells and an increase in the number and function of IL-10 producing T-regulatory cells (T-reg).

Towards a Clinical Decision Support System for Drug Allergy Management: Are Existing Drug Reference Terminologies Sufficient for Identifying Substitutes and Cross-Reactants?

cover

Allergy Risk Finder: Hypothesis Generation System for Allergy Risks via Web Service

cover

An eHealth Approach to Reporting Allergic Reactions to Food and Closing the Knowledge Gap

cover

September 17, 2015

To Assess the Quality of Life in Patients Suffering from Allergic Rhinitis



Journal of Basic & Applied Sciences

Journal of Basic & Applied Sciences- Medical Sciences Pages 501-506

Nikhil Sharma, Prithpal S. Matreja, Monika Gupta, Vipan Gupta,Manish Gupta and Ashwani K. Gupta

Open Access
Abstract: Background: Allergic Rhinitis (AR) associated with impairments in patients day-to-day functioning at home and work is a global health problem. It’s associated with sleep disorders, emotional problems, impairment in activities, and social functioning. However, it’s not known to what extent quality of life (QOL) scores, work impairment, or sleep is altered in Indian setup hence, this study was designed to assess the quality of life of patients suffering from allergic rhinitis.